YAP1 and liver cancer: Finally, we also discovered novel inhibitors of SMARCAL1 activity against liver cancer and YAP activity through virtual screening and western blot assay.<h4>Results</h4>SMARCAL1 exhibited increased expression in LIHC and was linked to unfavorable outcomes for patients.